tiprankstipranks
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market
2367
Giant Biogene Holding Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2367 full AI Analyst Report?

Giant Biogene Holding Co. Ltd. (2367) Income Statement

11 Followers

Giant Biogene Holding Co. Ltd. Income Statement

Last quarter (Q4 2025), Giant Biogene Holding Co. Ltd.'s total revenue was ¥2.37B, an increase of 23.31% from the same quarter last year. In Q4, Giant Biogene Holding Co. Ltd.'s net income was ¥720.53M. See Giant Biogene Holding Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 5.38B¥ 5.54B¥ 3.52B¥ 2.36B¥ 1.55B
Gross Profit
¥ 4.32B¥ 4.55B¥ 2.95B¥ 2.00B¥ 1.35B
Operating Expenses
¥ 2.25B¥ 2.24B¥ 1.28B¥ 817.32M¥ 425.62M
Depreciation and Amortization
¥ 80.12M¥ 31.62M¥ 34.17M¥ 27.63M¥ 23.07M
EBITDA
¥ 2.14B¥ 2.31B¥ 1.78B¥ 1.21B¥ 933.64M
Operating Income
¥ 2.06B¥ 2.31B¥ 1.66B¥ 1.13B¥ 914.57M
Other Income/Expenses
¥ 224.73M¥ 149.12M¥ 80.22M¥ 44.61M¥ 62.34M
Pretax Income
¥ 2.29B¥ 2.46B¥ 1.75B¥ 1.18B¥ 972.92M
Net Income
¥ 1.87B¥ 2.06B¥ 1.45B¥ 1.00B¥ 828.13M
Per Share Metrics
Basic EPS
¥ 1.78¥ 2.10¥ 1.49¥ 0.99¥ 0.84
Diluted EPS
¥ 1.76¥ 2.06¥ 1.48¥ 0.98¥ 0.84
Weighted Average Shares Outstanding
 1.05B 1.00B 980.91M 976.00M 974.79M
Weighted Average Shares Outstanding (Diluted)
 1.06B 1.00B 982.72M 1.02B 991.61M
Currency in CNY

Giant Biogene Holding Co. Ltd. Earnings and Revenue History